Carlos Abud-Mendoza

19PUBLICATIONS
82CO-AUTHORS
Adolescent healthLiquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Toxicology (incl. clinical toxicology)Major global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 13, 2026
Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+-year results from a multicenter, open-label study.

|Apr 28, 2026
Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohorts.

|Nov 28, 2025
Calcineurin inhibitors for initial induction treatment of lupus nephritis in children.

Fernando Martínez de la Hoya, David Alejandro Herrera-van Oostdam, Carlos Abud-Mendoza

|Oct 08, 2025
Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial.

Nicolino Ruperto, Daniel J Lovell, Olga Synoverska

|Jan 08, 2025
Challenges and Opportunities for Adult Vaccine Coverage: Insights for Healthcare Professionals Focusing on Herpes Zoster in Mexico.

María Yolanda Cervantes-Apolinar, Adriana Guzman-Holst, Abiel Mascareñas De Los Santos

|Apr 26, 2024
Risk factors for hospitalization in Mexican patients with systemic lupus erythematosus.

Iveth Eunice García-Cañas, Enrique Cuevas-Orta, David Alejandro Herrera-Van Oostdam

Pageof 4

Frequent Collaborators

4 joint publications

Hermine I Brunner

3 joint publications

Nicolino Ruperto

3 joint publications

Daniel Lovell

2 joint publications

José Luis Ayala-Herrera